Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$24.28
0.652.75%
At close: Aug 14, 5:00 PM EST
$24.28
N/A
After Hours: 4:00 PM EST
Bicara Therapeutics Inc
BCAXNASDAQ
Earnings: Q2 2026 Earnings were released on Tue Aug 11th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 3 days agoClick to view the webcast
Bicara Therapeutics Market Sentiment
Market sentiment signals for Bicara Therapeutics (BCAX): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 20.4% short float
Options Flow▲ 0.41 P/C ratio
Insider Activity— Neutral (30d)
Analyst Consensus
Buy
14 analysts
Options Flow (P/C)
0.41
More calls — Bullish
85 calls · 35 puts
Avg Consensus PT
$32
+33.1%
Highest Price Target
$47
+93.6%
Stifel
Lowest Price Target
$13
-46.4%
Cantor Fitzgerald
Short Interest
20.4%
Rising — Bearish
Insider Activity (30d)
Neutral
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Goldman Sachs | Richard Law— | -17.6% | $18 → $20 | Maintained | Neutral |
| Aug 12, 2026 | Wedbush | David Nierengarten— | +35.9% | $30 → $33 | Maintained | Outperform |
